Our vision: individualize cancer medicine
IR Side Nav
Investor Contact Sylke Maas, Ph.D.
VP Investor Relations & Business Strategy
Send Email
+49 6131 9084-0
VP Investor Relations & Business Strategy
Send Email
+49 6131 9084-0
Media Contact Jasmina Alatovic
Director Global External Communications
Send Email
+49 6131 9084-0
Director Global External Communications
Send Email
+49 6131 9084-0
SEC Filings
Filing date | Description | Form | View |
---|---|---|---|
FWP |
FWP | View HTML | |
FWP |
FWP | View HTML | |
This filing is a pre-effective amendment to an F-1 filing |
F-1/A | View HTML | |
Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act |
6-K | View HTML | |
Registration of up to an additional 20% of securities for an offering filed on an F-1 |
F-1MEF | View HTML | |
EFFECT |
EFFECT | View HTML | |
Registration statement for certain foreign private issuers |
F-1 | View HTML | |
Registration statement for certain foreign private issuers |
F-1 | View HTML | |
Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act |
6-K | View HTML | |
Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act |
6-K | View HTML |
Displaying 71 - 80 of 142 results
Data provided by Kaleidoscope.